Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of TNS power Rostov-on-Don approved dividends

9/23/24 RTSB

Nornickel may invest in mining projects in Kazakhstan

9/23/24 GMKN

Shareholders of TNS energy Voronezh approved dividends

9/23/24 VRSB

TGC-14 holds SPO

9/23/24 TGKN

Gazprom to maximize supplies through the Power of Siberia ahead of schedule

9/20/24 GAZP

Shareholders of Avangard Bank approved dividends

9/20/24 AVAN

Tatneft shareholders have not yet approved dividends

9/20/24 TATN

UTair passenger traffic on airplanes in January-August increased by 4.5%

9/20/24 UTAR

Yandex may buy Take Charge

9/20/24 YDEX

EuroTrans has published an offer to buy back shares in 2027

9/19/24 EUTR